Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1991-8-26
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0735-1097
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
18
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
366-7
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1906903-Anilides,
pubmed-meshheading:1906903-Anti-Arrhythmia Agents,
pubmed-meshheading:1906903-Arrhythmias, Cardiac,
pubmed-meshheading:1906903-Child,
pubmed-meshheading:1906903-Encainide,
pubmed-meshheading:1906903-Flecainide,
pubmed-meshheading:1906903-Humans,
pubmed-meshheading:1906903-Risk Factors
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Encainide and flecainide in children: separating the wheat from the chaff.
|
| pubmed:publicationType |
Editorial,
Comment
|